Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 6—June 2011
Research

Methicillin-Resistant Staphylococcus aureus, Samoa, 2007–2008

James Alesana-Slater, Stephen R. RitchieComments to Author , Helen Heffernan, Tracy Camp, Alice Richardson, Peter Herbison, and Pauline Norris
Author affiliations: Author affiliations: University of Otago, Dunedin, New Zealand (J. Alesana-Slater, P. Herbison, P. Norris); University of Auckland, Auckland, New Zealand (S.R. Ritchie); Institute of Environmental Science and Research Limited, Wellington, New Zealand (H. Heffernan, A. Richardson); Auckland City Hospital, Auckland (T. Camp)

Main Article

Table 1

Demographic characteristics of study participants and prevalence of MSSA and MRSA, Samoa, summer 2007–2008*

Characteristic Total study population No. (%, 95% CI)
S. aureus positive MSSA MRSA
No. participants
 399
 187 (47, 42–52)
 153 (38, 34–43)
 34 (9, 6–12)
Male sex
 263
 121 (46, 40–52)
 95 (36, 31–42)
 26 (10, 7–14)
Age, y†
<5 53 37 (70, 56–81)‡ 33 (62, 49–74) 4 (8, 3–18)
5–15 93 50 (54, 44–64) 44 (47, 38–57) 6 (7, 3–14)
16–59 195 79 (34–48) 60 (31, 25–38) 19 (10, 6–15)
>60
 58
 21 (36, 25–49)
 16 (28, 18–40)
 5 (9, 3–19)
Antimicrobial drug treatment in previous month 224 84 (38, 31–44)§ 67 (30, 24–36) 17 (8, 5–12)
Health care contact in previous 3 months 262 108 (41, 35–47) 85 (32, 27–38) 23 (9, 6–13)

*MSSA, methicillin-susceptible Staphylococcus aureus, MRSA, methicillin-resistant S. aureus; CI, confidence interval.
†Median age, y (range) of study participants: All, 32 (0–89); S. aureus positive, 24 (0–84); MSSA positive, 26 (0–84); MRSA positive, 36 (0–76).
‡p<0.001, S. aureus positive vs. study population >5 y of age.
§p<0.001, S. aureus positive vs. no antimicrobial drug treatment in the previous month.

Main Article

Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external